- advertisement -

Humana - CGM policy

Discussion in 'Insurance Issues' started by Ellen, Sep 5, 2008.

  1. Ellen

    Ellen Senior Member

    Joined:
    Oct 22, 2005
    Messages:
    8,240
    Humana Coverage Issues

    Humana Coverage Issues

    Continuous Glucose Monitoring Systems
    Continuous glucose monitoring systems (CGMS) are devices that measure glucose levels in interstitial fluid at programmable intervals. These readings, used along with fingerstick results, help detect any patterns or trends with a patient�s glucose levels and are intended to assist in calculating the insulin dosage needed to manage glycemic control. Invasive CGMS use sensors that are inserted under the skin in the abdomen and work by extracting glucose from the interstitial fluid, measure and record the glucose level and convert these measurements into equivalent blood glucose readings. Sensors are designed to be worn three to seven days, depending on the product. Calibration is required whenever a new glucose sensor is inserted, which requires obtaining blood glucose from a traditional fingerstick sample. CGMS readings are intended to supplement, not replace, fingersticks.
    CI[​IMG]Read Me Now [​IMG] 2008-8-28

    http://apps.humana.com/tad/tad_new/returnContent.asp?mime=application/pdf&id=6222&issue=855
     

Share This Page

- advertisement -

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice